Iron compounds and resistance to infection. Further experiments with Clostridium welchii type A in vivo and in vitro.
D000818:Animals; D000992:Antitoxins; D001609:Beta-Globulins; D001770:Blood Bactericidal Activity; D003016:Clostridium perfringens / Q000187:drug effects* / Q000254:growth & development; D005738:Gas Gangrene / Q000175:diagnosis / Q000517:prevention & control*; D006168:Guinea Pigs; D006418:Heme / Q000494:pharmacology*; D006454:Hemoglobins / Q000494:pharmacology*; D006736:Horses; D007501:Iron / Q000494:pharmacology* / Q000627:therapeutic use; D008161:Lumbosacral Region; D010084:Oxidation-Reduction; D011379:Prognosis; D012709:Serum Albumin; D013743:Tetanus Antitoxin; D014168:Transferrin / Q000494:pharmacology*; D005719:gamma-Globulins
D000992:Antitoxins; D001609:Beta-Globulins; D006454:Hemoglobins; D012709:Serum Albumin; D013743:Tetanus Antitoxin; D014168:Transferrin; D005719:gamma-Globulins; D006418:Heme; D007501:Iron